I-Salvianolic acid A CAS No. 96574-01-5
Ulwazi oluBalulekileyo
Isifaniso:Salvianolic acid A, (2R) - 3 - (3,4-dihydroxyphenyl) - 2 - [(E) - 3 - [(E) - 2 - (3,4-dihydroxyphenyl) vinyl] - 3,4-dihydroxyphenyl] propyl-2-enoyl] oxypropionic acid, (2R) - 3 - (3,4-dihydroxyphenyl) - 2 - [(E) - 3 - [(E) - 2 - (3,4-dihydroxyphenyl) ethenyl] - 3 ,4-dihydroxyphenyl] prop-2-enoyl] oxypropionic acid
Inombolo yeCAS:96574-01-5
Imowudi yokubona:HPLC ≥ 98%
Iinkcukacha:20mg, 50mg, 100mg, 500mg, 1g (inokupakishwa ngokweemfuno zabathengi)
Umlinganiswa:Le mveliso yikristale etyheli ekhanyayo
Umsebenzi kunye nokusetyenziswa:Le mveliso isetyenziselwa ukumisela umxholo.
Umthombo wokutsalwa:Le mveliso Salvia miltiorrhiza Bge Kwingcambu ye.
IiPropathi zePharmacological:Inyibilika kwi-ethanol kunye ne-ether.Indawo yokunyibilika 315 ~ 323 ℃
Ukusetyenziswa:Iimeko zeChromatographic: isigaba seselula: i-45 methanol-1% i-acetic acid yamanzi (45:55) izinga lokuhamba: 1ml / min ukufumanisa ubude be-wavelength: 286nm (ngokubhekiselele kuphela)
Indlela yokugcina:2-8 ° C, gcina kwindawo epholileyo neyomileyo kwaye ugcine kude nokukhanya.
Imibandela Efuna Ingqalelo
Le mveliso kufuneka igcinwe kwiqondo lokushisa eliphantsi.Ukuba ibonakaliswe emoyeni ixesha elide, umxholo uya kuncitshiswa.
Ifanelekile kwi-angina pectoris kunye ne-acute myocardial infarction.Ikwasebenza ngempumelelo kwi-sequelae ye-cerebral thrombosis.Ukongeza, ingasetyenziselwa i-thromboangiitis obliterans, i-scleroderma, i-embolism ye-retinal embolism, ubuthulu be-nerve, i-white thiazide syndrome kunye ne-nodular erythema.
